A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2007
10/25/2007	US20070249524 High affinity ligands bind to clostridium difficile toxin A
10/25/2007	US20070249523 Neurotherapeutic composition and method therefor
10/25/2007	US20070249522 Injectable formulations containing succinate
10/25/2007	US20070249520 Stable emulsion formulations
10/25/2007	US20070249519 Methods for the upregulation of glut4 via modulation of ppar delta in adipose tissue and for the treatment of disease
10/25/2007	US20070249509 Neutralizes the adverse health effects of both chemical and biological compounds, especially chemical warfare (CW) and biological warfare (BW) agents
10/25/2007	US20070249051 Vinyl-phenyl derivatives for inflammation and immune-related uses
10/25/2007	US20070249050 Substituted aromatic compounds for inflammation and immune-related uses
10/25/2007	US20070249049 For modulating gene expression pathways, including those relying on mechanisms of action such as RNaseH, RNAi and dsRNA enzymes, as well as other antisense mechanisms based on target degradation or target occupancy; of therapeutic, diagnostics, and research applications; nuclease resistance
10/25/2007	US20070249048 useful as immunosuppressive, anti-inflammatory and anticancer agents; prepared by reaction of a starting triptolide compound with selenium dioxide.
10/25/2007	US20070249043 Adenoviral expression vectors
10/25/2007	US20070249033 Methods of terminal sterilization of biological products
10/25/2007	US20070249031 Aminopyrimidines useful as kinase inhibitors
10/25/2007	US20070249010 Methods for treating glaucoma and macular degeneration
10/25/2007	US20070249009 Compositions and methods for altering RNAi
10/25/2007	US20070248955 Use Of Genetic Polymorphisms To Predict Drug-Induced Hepatotoxicity
10/25/2007	US20070248944 administering an enzyme inhibitor of c-Jun N-terminal Kinase (JNK), Anthra[1-9-cd]pyrazol-6(2H)-one for treating the vascular aneurysm
10/25/2007	US20070248702 Use of CB2 receptors agonists for the treatment of Huntington's disease
10/25/2007	US20070248698 Obesity and Metabolic Syndrome Treatment with Tanshinone Derivatives Which Increase Metabolic Activity
10/25/2007	US20070248697 Opthalmic solutions
10/25/2007	US20070248696 Composition and method for enhancing neuromuscular facilitation and cognitive functions
10/25/2007	US20070248694 Anti-inflammatory properties of a standardized extract from Euphorbia hirta (PM-251) activity and for treating conditions of inflammation
10/25/2007	US20070248692 Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents
10/25/2007	US20070248690 glutamate antagonist, cAMP stimulating agent, antioxidant, vitamin B12, transporter and surfactant; for alleviating tinnitus, Meniere's Disease and/or hearing loss
10/25/2007	US20070248688 Animal repellent composition and method
10/25/2007	US20070248686 Colloidal suspension of submicronic particles as vectors for active principles and method for preparing same
10/25/2007	US20070248679 Vaccine
10/25/2007	US20070248677 Method for treating warm-blooded vertebrates with a salt of a halide-free glucosamine base and a therapeutic drug
10/25/2007	US20070248676 Use of nitric oxide adducts
10/25/2007	US20070248672 Indole and Azaindole Derivatives with Antitumor Action
10/25/2007	US20070248671 Asymmetric membranes for drug delivery devices
10/25/2007	US20070248670 Tolterodine beads
10/25/2007	US20070248669 Oral sustained release formulation
10/25/2007	US20070248668 Pharmaceutical compositions and uses thereof
10/25/2007	US20070248667 Tannate Compositions and Methods of Use
10/25/2007	US20070248666 Granules Comprising a Beta-Lactam Antibiotic
10/25/2007	US20070248665 Compositions comprising co-precipitate of eplerenone and a water-soluble excipient
10/25/2007	US20070248664 Oral Antimicrobial Pharmaceutical Compositions
10/25/2007	US20070248663 Utilization of Dialkylfumerates
10/25/2007	US20070248662 Immunosuppressants; for use in transplantation medicine or treatment of autoimmune diseases such as polyarthritis but not psoriatitc arthritis; micro-tablets, pellets
10/25/2007	US20070248659 Individualized cancer therapy
10/25/2007	US20070248658 Use of film-forming hair care polymers from the group of polyurethanes and pharmaceutical preparations and patches that contain these polymers
10/25/2007	US20070248657 Multi-compartment transdermal pain control device
10/25/2007	US20070248656 Topical preparation dispensers and methods of using the same
10/25/2007	US20070248654 Protective mouth sore discs made with corn starch
10/25/2007	US20070248653 Hemostatic compositions and methods for controlling bleeding
10/25/2007	US20070248651 Formulation for treatment of acne
10/25/2007	US20070248649 Of soluble and insoluble carbohydrates for dietetics and pharmaceuticals to promote the flora of the large intestine, lactic acid bacteria, and in infant formulas; probiotics
10/25/2007	US20070248648 High protein, fatigue reducing powder
10/25/2007	US20070248646 Use of azurocidin inhibitors in prevention and treatment of ocular vascular leakage
10/25/2007	US20070248643 Polymerizable emulsions for tissue engineering
10/25/2007	US20070248641 Use of Del-1 in Hair, Bone and Cartilage Regeneration
10/25/2007	US20070248639 Cyclooxygenase inhibitor and calcium channel antagonist compositions and methods for use in urological procedures
10/25/2007	US20070248633 Compositions containing a hydroxylated diphenylmethane compound, methods of use
10/25/2007	US20070248630 Pharmaceutical formulations for iontophoretic methotrexate delivery
10/25/2007	US20070248629 Pharmaceutical formulations for iontophoretic drug delivery
10/25/2007	US20070248627 Gene Therapy for Tumors Using Minus-Strand Rna Viral Vectors Encoding Immunostimulatory Cytokines
10/25/2007	US20070248624 (1,10B-Dihydro-2-(Aminocarbonyl-Phenyl)-5h-Pyrazolo[1,5-C][1,3]Benzoxazin-5-Yl)Phenyl Methanone Derivatives as Hiv Viral Replication Inhibitors
10/25/2007	US20070248621 Food product containing policosanols
10/25/2007	US20070248620 Method of treating malignancies and viral infections and improving immune function with a dietary supplement
10/25/2007	US20070248609 Therapeutic Method
10/25/2007	US20070248599 Treatment of alzheimer's disease with inhibitors of apoe binding to apoe receptor
10/25/2007	US20070248594 Cxcr1 and cxcr2 chemokine antagonists
10/25/2007	US20070248593 Identifying and characterizing novel human secreted proteins and their genes ; promotes vascularization; screening methods
10/25/2007	US20070248590 Modulators of CDC2-like kinases (CLKS) and methods of use thereof
10/25/2007	US20070248588 Novel Compositions and Methods for the Treatment of Immune-Related Diseases
10/25/2007	US20070248586 Oxylipins from stearidonic acid and gamma-linolenic acid and methods of making and using the same
10/25/2007	US20070248579 Use of Secreted Protein Products for Preventing and Treating Pancreatic Diseases and/or Obesity and/or Metabolic Syndrome
10/25/2007	US20070248577 Methods and compositions for administering stem cells
10/25/2007	US20070248572 Method for treating diseases with omega interferon
10/25/2007	US20070248570 Pharmaceutical Compositions Containing Platinum Complexes with Secondary Xanthates and Therapeutic Uses Thereof
10/25/2007	US20070248569 Eye-Drop Vaccine Containing Copolymer 1 for Therapeutic Immunization
10/25/2007	US20070248566 Antimicrobial polyisocyanate and derivatives thereof
10/25/2007	US20070248565 Pharmaceutical preparations comprising corticosteroids and antiinfective agents
10/25/2007	US20070248564 Formulation of sodium polystyrene sulfonate suspension for the treatment of hyperkalemia
10/25/2007	US20070248556 Administration of C-glycoside compounds for activating and regulating cutaneous immunity
10/25/2007	US20070248554 Hair Style Control Agent
10/25/2007	US20070248548 Stable hydroalcoholic oral spray formulations and methods
10/25/2007	US20070248543 Chicken Deoxycytidine and Deoxyadenosine Kinase Enzymes and Their Use
10/25/2007	US20070248541 Liposome
10/25/2007	US20070248535 Methods to treat or prevent hormone-resistant prostate cancer using siRNA specific for protocadherin-PC, or other inhibitors of protocadherin-PC expression or activity
10/25/2007	US20070248534 Auger effect-based cancer therapy method
10/25/2007	US20070248486 Process for Sterilization of Cyanoacrylate Adhesive Compositions and Devices
10/25/2007	DE202005021371U1 Oxycodonhydrochlorid mit weniger als 25 ppm 14-Hydroxycodeinon Oxycodone hydrochloride with less than 25 ppm 14-hydroxycodeinone
10/25/2007	DE10221055B4 Verbindungen zur hämokompatiblen Beschichtung von Oberflächen, Verfahren zu deren Herstellung und deren Verwendung Compounds for the hemocompatible coating of surfaces, processes for their preparation and their use
10/25/2007	DE102007018552A1 Aufbewahrungssystem für Temozolomid Storage system for temozolomide
10/25/2007	DE102006020492A1 Verwendung von Acetylsalicylsäure (ASS) beim Einsatz einer Membranlunge Use of acetylsalicylic acid (ASA) with the use of a membrane lung
10/25/2007	DE102006018912A1 1,4:3,6-Dianhydromannitol-Derivate und deren Verwendung 1,4: 3,6-Dianhydromannitol derivatives and their use
10/25/2007	DE102006018888A1 Verfahren zur Herstellung von 4-[17beta-Methoxy-17alpha-methoxymethyl-3-oxoestra-4,9-dien-11beta-yl]benzaldehyd-(E)-oxims (Asoprisnil) Process for the preparation of 4- [17beta-methoxy-17alpha-methoxymethyl-3-oxoestra-4,9-dien-11beta-yl] benzaldehyde (E) -oxime (asoprisnil)
10/25/2007	DE102006017896A1 Leflunomid enthaltende pharmazeutische Zusammensetzungen Leflunomide pharmaceutical compositions containing them
10/25/2007	DE102006017672A1 Zusammensetzung zur Verwendung als Laxativum A composition for use as a laxative
10/25/2007	DE102006012161A1 Neue Verwendung von N-Acetyl-mannosamin oder Derivaten hiervon New use of N-acetyl-mannosamine or derivatives thereof
10/25/2007	DE102004002884B4 Aspernigrin B und Aspernigrin-B-Derivate, sie enthaltende pharmazeutische Zusammensetzungen und deren Verwendung Aspernigrin B-B and Aspernigrin derivatives, pharmaceutical compositions containing them and their use
10/25/2007	CA2839228A1 Method for preparing 4-[17.beta.-methoxy-17.alpha.-methoxymethyl-3-oxoestra-4,9-dien-11.beta.-yl]benzaldehyde (e)-oxime (asoprisnil)
10/25/2007	CA2725810A1 Tetomilast polymorphs
10/25/2007	CA2725698A1 Tetomilast polymorphs
10/25/2007	CA2725649A1 Tetomilast polymorphs
10/25/2007	CA2683756A1 Method of treatment of age-related macular degeneration(amd)
10/25/2007	CA2650998A1 Liquid composition for external application and preparation for external application for treatment of skin ulcer
10/25/2007	CA2650534A1 Co-crystals of calixarenes and biologically active molecules

1 ... 3531 3532 3533 3534 3535 3536 3537 3538 3539 3540 3541 3542 3543 3544 3545 3546 3547 3548 3549 3550 3551 ... 7860